Neudle.com: multiple sclerosis cost of

Differential
(Click to cross reference)

abdominal reflex, absent

acetylcholine receptor

acetylcholine receptor antibody

acute disseminated encephalomyelitis

addiction, heroin

addiction, heroin-neurologic complications with

advances in neurology

adverse drug reaction

alemtuzumab

algorithm

amphiphysin antibodies

amyotrophic lateral sclerosis

ANA

angiotensin-converting enzyme

anti MAG antibodies

anti Ro antibody

area postrema

area postrema syndrome

basal ganglia, lesion of

CAT scan, emission, abnormal

CAT scan, indications for

central nervous system, infection of

cerebral edema, vasogenic

cerebral peduncle

cerebral vasculature

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, oligoclonal bands, absent

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, mimics

cervical spine manipulation

children

chiropractic manipulation

chorioretinitis

cladribine

Clinical Pathologic Conference(C.P.C.)

collapsin response mediator protein 5 IgG

controversies in neurology

conversion reaction

cop 1

corpus callosum

corpus callosum, lesion of

cytomegalovirus infection

demyelinating disease

dermatomyositis

diagnostic criteria

diencephalon

differential diagnosis

diplopia

disability, neurological

disease modifying agents

electroencephalogram, abnormalities of

embolism

embolism, cholesterol

employment

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalomyelitis

encephalomyelitis, postinfectious

encephalopathy

epidemiology of neurology

evidence-based research

fourth ventricle, floor

fumarate

gadolinium

gag reflex, depressed

gammaglobulin therapy, intravenous

gender

gray matter

Guillain Barre syndrome

heralding manifestation

herpes zoster

hiccoughs

hiccoughs, intractable

hyponatremia with cerebral disorders

hypothalamus

hypothalamus, damage to

hypothalamus, lesion of

hypothermia

iatrogenic neurologic disorders

idiopathic

immunohistochemistry

immunology and the nervous system

immunomodulation

immunosuppressive agents

immunotherapy

inappropriate antidiuretic(A.D.H.)hormone

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

inclusion body myositis

inebilizumab

infection

infliximab

intellectual deterioration

intracerebral hemorrhage

lesions too numerous to count

leukoencephalitis, acute necrotizing hemorrhagic

leukoencephalopathy

level of consciousness, decreased

limbic encephalitis

linear lesion

lipoprotein receptor-related protein 4

lumbar spine manipulation

lymphadenopathy

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

mammillary bodies

managed care

marihuana

McDonald criteria for MS

medical-legal aspects of neurology

medulla oblongata

medulla oblongata, lesion of

meningeal enhancement

mental status, abnormal

mesial temporal sclerosis

methotrexate

microangiopathy, spinal cord

microemboli

midbrain, lesion of

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebellar peduncle, lesion, bilateral

migraine

migraine, cost of

migraine, treatment of

mimics

misdiagnosis

mitoxantrone

monoclonal antibodies

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, demyelinating disease

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, field strength, high

MRI, spinal cord, increased intramedullary cord signal

MRI, spine

MRI, susceptibility weighted

MRI, target sign

MRS

multiple sclerosis

multiple sclerosis, clinical patterns

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, epidemiology of

multiple sclerosis, late-onset

multiple sclerosis, lesion location

multiple sclerosis, misdiagnosis

multiple sclerosis, pathogenesis

multiple sclerosis, prognosis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, spinal form

multiple sclerosis, treatment of

multiple sclerosis, tumefactive

multiple sclerosis, without CSF bands

multiple sclerosis, work up for

multiple system atrophy

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myasthenic crisis

myasthenic syndrome

myasthenic syndrome, treatment of

myelitis, longitudinal

myelitis, post infectious

myelitis, transverse

myelitis, transverse, idiopathic

myelitis, transverse, prognosis

myelitis, transverse, recurrent

myelopathy, necrotizing

myocarditis

myofascial pain syndrome

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic disease, multiple

neurologic evaluation

neurologic symptoms, unexplained

neurology clinic

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica (Devic's disease), screening

neuromyelitis optica spectrum disorder

neuromyelitis optica, IgG

neuropathology

neuropathology, brain

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, multifocal

neuropathy, peripheral, treatment

neuroradiology

NMDA antagonists

Oculinum

old age, neurology of

ophthalmoplegia

opportunistic infection

optic chiasm

optic chiasm, lesion of

optic nerve

optic nerve, enhancement

optic nerve, lesion of

optic neuritis

optic neuritis, alternating

optic neuritis, bilateral

optic neuritis, recurrent

optic neuropathy

optic neuropathy, ischemic

optical coherence tomography

outcome research

ovarian tumor

owl's eye sign of spinal cord

Parkinsonism syndrome

pathology

patient information and support

periaqueductal lesion

pleocytosis of cerebrospinal fluid

pleocytosis of cerebrospinal fluid, neutrophilic

polymyositis

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

rehabilitation for neurologic disorders

remission

remote effect of cancer on the nervous system

respirator

respiratory failure

retinal lesion

reversible neurologic disorder

review article

risk factors

risk-benefit assessment

scleroderma, neurologic involvement with

screening

sedimentation rate, elevated

seizure

seizure, intractable

seizure, intractable, treatment of

seizure, surgical treatment of

seizure, treatment of

sensory level

serologic testing

serologic testing of cerebrospinal fluid

serologic testing, false negative

seronegative

seropositive

shared decision making

single photon emission computed tomography

sinusitis

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

skin, lesions in neurologic disorders

somnolence

spasticity

spasticity, treatment of

spinal cord

spinal cord, biopsy

spinal cord, compression of

spinal cord, dorsal subpial enhancement

spinal cord, enlargement

spinal cord, infarction of

spinal cord, lesion of

spinal cord, neoplasm

splenium of corpus callosum

sprain, cervical

sprain, cervical-treatment of

staphylococcal protein A column therapy

steroid

steroid therapy, CNS treatment and complications with

stiff man syndrome

strain, back

subarachnoid hemorrhage

sumatriptan

sweet taste

symmetric brain lesions

syringomyelia

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

temporal lobe, lesion

temporal lobe, lesion, bilateral

tender points

teriflunomide

thalamus, lesion of

thalamus, lesion of-bilateral

third ventricle, wall

transient neurologic deficit

trauma

treatment of neurologic disorder

tuberculosis

tumefactive lesion

ultrasonography

ultrasonography, carotid artery

vision loss, sequential

vision, blurred

visual acuity

visual evoked response

visual loss

visual loss, progressive

visual loss, sudden

vomiting, intractable

Wallerian degeneration

water channel antibodies

weakness

weakness, acute

weakness, fatiguable

weakness, generalized

weakness, progressive

white matter disease

white matter disease, periventricular

whites

work loss

workers' compensation

workup

Showing articles 100 to 150 of 4419 << Previous Next >>

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

Brain Abnormalities in Neuromyelitis Optica
Arch Neurol 63:390-396, Pittock,S.J.,et al, 2006

Revised Diagnostic Criteria for Neuromyelitis Optica
Neurol 66:1485-1489, Wingerchuk,D.M.,et al, 2006

Neuromyelitis Optica IgG Status in Acute Partial Transverse Myelitis
Arch Neurol 63:1398-1400, Scott,T.F.,et al, 2006

Intractable Hiccup and Nausea With Pariaqueductal Lesions in Neuromyelitis Optica
Neurol 65:1479-1482, Misu,T.,et al, 2005

Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004

The Natural History of Recurrent Optic Neuritis
Arch Neurol 61:1401-1405, Pirko,I.,et al, 2004

A Serum Autoantibody Marker of Neuromyelitis Optica: Distinction from Multiple Sclerosis
Lancet 364:2106-2112, Lennon,V.A.,et al, 2004

Neuromyelitis Optica:What It Is and What It Might Be
Lancet 361:889-890, Weinshenker,B.G., 2003

Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost?
JNNP 70:574-579, Bryan,J.,et al, 2001

Familial Neuromyelitis Optica (Devics Syndrome) with Late Onset in Japan
Neurol 55:318-320, Yamakawa,K.,et al, 2000

Burden of Migraine in the United States, Disability and Economic Costs
Arch Int Med 159:813-818, Hu,X.H.,et al, 1999

Changes in Resource Use and Outcomes for Patients with Migraine Treated with Sumatriptan, A Managed Care Perspective
Arch Int Med 159:857-863, Lofland,J.H.,et al, 1999

The Clinical Course of Neuromyelitis Optica (Devic's Syndrome)
Neurol 53:1107-1114, Wingerchuk,D.M.,et al, 1999

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999

Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999

Optic Neuritis in African Americans
Arch Neurol 55:186-192, Phillips,P.H.,et al, 1998

Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998

Devic's Neuromyelitis Optica:A Prospective Study of Seven Patients Treated with Prednisone and Azathioprine
Neurol 51:1219-1220, Mandler,R.N.,et al, 1998

Tolterodine for Overactive Bladder
The Medical Letter 40:101-102, , 1998

Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter 39:61-62, , 1997

The Quality-of-Life Effects of Interferon Beta-1b in MS
Arch Neurol 54:1475-1480, Schwartz,C.E.,et al, 1997

Problems with Myofascial Pain Syndrome and Fibromyalgia Syndrome
Neurol 46:593-597, Bohr,T., 1996

Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996

The Hidden Costs of Medicolegal Abuses in Neurology
Arch Neurol 51:650-652, Scheinberg,P., 1994

Devic's Neuromyelitis Optica:A Clinicopathological Study of 8 Patients
Ann Neurol 34:162-168, Mandler,R.N.,et al, 1993

Update on Surgical Treatment of the Epilepsies, Second Intern Palm Desert Conf on Surgical Trtm of Epilepsies (1992)
Neurol 43:1612-1617, Engel,J.Jr., 1993

Neuromyelitis Optica (Devic's Syndrome) and Pulmonary Tuberculosis
Neurol 40:934-938, Silber,M.H.,et al, 1990

Disseminated Cholesterol Embolism Presenting as Neuromyelitis Optica
BMJ 295:697, Goldman,M.,et al, 1987

MR Imaging of Spinal Cord in Devic Disease
J Comput Assist Tomogr 11:516-517, Tashiro,K.,et al, 1987

Neuromyelitis Optica in the Elderly
Arch Neurol 41:670-672, Filley,C.M.,et al, 1984

Devic's Syndrome & Systemic Lupus Erythematosus, A Case Report With Necropsy
Arch Neurol 36:643-644, Kinney,E.L.,et al, 1979

A Case of Neuromyelitis Optica (Devic's syndrome) in Systemic Lupus Erythematosus
Neurol 26:1066, April,R.S.,et al, 1976

Prognosis in Acute Disseminated Encephalomylitis; (With a Note on Neuromyelitis Optica)
Quart J Med 347, 1953, July., Miller,H.,et al, 1953

Progress Toward Mitigating Disability Progression in Multiple Sclerosis
NEJM 392:1966-1968, Calabresi,P.A., 2025

Slowly Expanding Lesions Differentiate Pediatric Multiple Sclerosis from Myelin Oligodendrocyte Glycoprotein Antibody Disease
Ann Neurol 96:1086-1091, Fadda,G.,et al, 2024

Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple Sclerosis
Ann Neurol 96:846-854, Marrodan,M.,et al, 2024

Decompressive Carniectomy Plus Best Medical Treatment Versus Best Medical Treatment Alone for Spontaneous Severe Deep Supratentorial Intracerebral Haemorrhage:A Randomised Controlled Clinical Trial
Lancet 403:2395-2404, Beck,J.,et al, 2024

Powassan Virus Encephalitis: A Tertiary Center Experience
Clin Inf Dis 78:80-89, Mendoza,M.A.,et al, 2024

Clinicopathologic Conference, Paraneoplastic Encephalomyelitis Due to Small-Cell Lung Carcinoma and Concurrent Cerebral Amyloid Angiopathy
NEJM< 391357-369, Case 23-2024, 2024

The Optic Nerve Should Graduate to Be the Fifth Lesion Site for the Diagnosis of Multiple Sclerosis
Neurol 102:e207919, Galetta,S. & Brownlee, W., 2024

Inhibition of CD40L with Frexalimab in Multiple Sclerosis
NEJM 390:589-600, 662, Vermersch,P.,et al, 2024

Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke
NEJM 389:2413-2424, 2478, Gao,Y.et al, 2023

Association of Very Early treatment Initiation with the Risk of Long-Term Disability in Patients with a First Demyelinating Event
Neurol 101:e1280-e1292, 549, Cobo-Calvo,A.,et al, 2023

Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity
Ann Neurol 94:146-159, Giraldo,G.S.P.,et al, 2023

Overlapping Anti-NMDAR Encephalitis and Multiple Sclerosis: A Case Report and Literature Review
Front Immunol doi:10.3389/Fimmun.2023.1088801, Liu,P.,et al, 2023

Management of Possible Multiple Sclerosis
NEJM 388:2195-2190, , 2023

Endovascular vs Medical Management for Late Anterior Large Vessel Occlusion With Prestroke Disability
Neurol 100:e751-e763, Siegler, J.E., et al, 2023

Dramatic Response to Topiramate in Acquired Pendular Nystagmus From Multiple Sclerosis
Neurol 100:47-48, Murphy,O.C. et al, 2023

Clinicopathologic Conference, Granulomatosis with Polyangiitis
NEJM 387:1022-1032, Case 28-2022, 2022

Showing articles 100 to 150 of 4419 << Previous Next >>